- Report
- July 2024
- 350 Pages
Global
From €2638EUR$2,655USD£2,193GBP
- Report
- March 2023
- 280 Pages
Global
From €3666EUR$3,690USD£3,048GBP
- Report
- October 2022
- 300 Pages
Global
From €3666EUR$3,690USD£3,048GBP
- Report
- October 2022
- 350 Pages
Global
From €3815EUR$3,840USD£3,172GBP
- Report
- September 2022
- 341 Pages
Global
From €3815EUR$3,840USD£3,172GBP
- Report
- October 2021
- 183 Pages
Global
From €3688EUR$3,712USD£3,066GBP
- Report
- March 2021
- 268 Pages
Global
From €3688EUR$3,712USD£3,066GBP
- Book
- October 2023
- 1552 Pages
- Book
- January 2020
- 240 Pages
- Book
- December 2018
- 424 Pages
- Book
- February 2025
- 256 Pages
- Book
- April 2022
- 288 Pages
- Book
- April 2014
- 432 Pages
- Book
- December 2011
- 368 Pages
- Book
- February 2011
- 366 Pages
- Book
- April 2009
- 584 Pages
- Book
- February 2008
- 1350 Pages
- Book
- January 2008
- 453 Pages
- Book
- January 2008
- 460 Pages
Pulmonary Medicine is a branch of medicine that focuses on the diagnosis and treatment of diseases and disorders of the lungs and respiratory system. It includes the diagnosis and treatment of asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, lung cancer, pulmonary hypertension, sleep apnea, and other respiratory conditions. Pulmonologists are medical doctors who specialize in the diagnosis and treatment of pulmonary diseases.
Pulmonary Medicine is a rapidly growing field, with new treatments and technologies being developed to improve the quality of life for those with respiratory conditions. Pulmonologists work closely with other medical professionals, such as allergists, cardiologists, and radiologists, to provide comprehensive care for their patients.
Some of the leading companies in the Pulmonary Medicine market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the development and marketing of drugs and treatments for pulmonary diseases. Show Less Read more